Rocket


News + Filings
Transactions


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Gilad Oren Create: Alert

All | News | Filings
Date FiledTypeDescription
03/13/2023 4 Gilad Oren (President, CEO) has filed a Form 4 on Aprea Therapeutics, Inc.
Txns: Converted 6,045,100 shares @ $0
Granted 4,000 shares @ $0
Converted 604,510 options to buy @ $0
Granted 16,000 options to buy @ $5.08, valued at $81.3k
08/01/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/26/2022 3 Form 3 - Initial statement of beneficial ownership of securities:

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy